ALNY logo

Alnylam Pharmaceuticals (ALNY) Total expenses

Annual total expenses:

$2.43B+$314.66M(+14.91%)
December 31, 2024

Summary

  • As of today (June 2, 2025), ALNY annual total expenses is $2.43 billion, with the most recent change of +$314.66 million (+14.91%) on December 31, 2024.
  • During the last 3 years, ALNY annual total expenses has risen by +$872.19 million (+56.16%).
  • ALNY annual total expenses is now at all-time high.

Performance

ALNY Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

Quarterly total expenses:

$576.11M-$122.21M(-17.50%)
March 31, 2025

Summary

  • As of today (June 2, 2025), ALNY quarterly total expenses is $576.11 million, with the most recent change of -$122.21 million (-17.50%) on March 31, 2025.
  • Over the past year, ALNY quarterly total expenses has increased by +$38.34 million (+7.13%).
  • ALNY quarterly total expenses is now -17.50% below its all-time high of $698.33 million, reached on December 31, 2024.

Performance

ALNY Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

ALNY Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.9%+7.1%
3 y3 years+56.2%+60.0%
5 y5 years+109.2%+86.1%

ALNY Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+56.2%-17.5%+60.0%
5 y5-yearat high+109.2%-17.5%+90.3%
alltimeall timeat high>+9999.0%-17.5%>+9999.0%

ALNY Total expenses History

DateAnnualQuarterly
Mar 2025
-
$576.11M(-17.5%)
Dec 2024
$2.43B(+14.9%)
$698.33M(+20.9%)
Sep 2024
-
$577.82M(-5.5%)
Jun 2024
-
$611.21M(+13.7%)
Mar 2024
-
$537.77M(-3.3%)
Dec 2023
$2.11B(+15.8%)
$556.12M(+3.6%)
Sep 2023
-
$536.66M(-2.2%)
Jun 2023
-
$548.59M(+16.9%)
Mar 2023
-
$469.10M(-10.4%)
Dec 2022
$1.82B(+17.4%)
$523.65M(+0.2%)
Sep 2022
-
$522.35M(+25.4%)
Jun 2022
-
$416.50M(+15.7%)
Mar 2022
-
$359.99M(-20.5%)
Dec 2021
$1.55B(+17.5%)
$453.10M(+22.7%)
Sep 2021
-
$369.31M(+0.7%)
Jun 2021
-
$366.71M(+0.8%)
Mar 2021
-
$363.82M(+1.7%)
Dec 2020
$1.32B(+14.0%)
$357.78M(+1.9%)
Sep 2020
-
$351.05M(+15.9%)
Jun 2020
-
$302.82M(-2.2%)
Mar 2020
-
$309.63M(-16.3%)
Dec 2019
$1.16B(+30.3%)
$369.75M(+29.1%)
Sep 2019
-
$286.36M(+1.9%)
Jun 2019
-
$280.99M(+26.5%)
Mar 2019
-
$222.08M(-8.0%)
Dec 2018
$889.58M(+50.8%)
$241.39M(-5.9%)
Sep 2018
-
$256.63M(+15.5%)
Jun 2018
-
$222.26M(+31.3%)
Mar 2018
-
$169.30M(-8.6%)
Dec 2017
$590.00M(+25.1%)
$185.23M(+29.6%)
Sep 2017
-
$142.90M(+4.8%)
Jun 2017
-
$136.41M(+8.7%)
Mar 2017
-
$125.47M(-5.6%)
Dec 2016
$471.75M(+39.9%)
$132.89M(+10.4%)
Sep 2016
-
$120.33M(+18.9%)
Jun 2016
-
$101.16M(-13.8%)
Mar 2016
-
$117.37M(+17.3%)
Dec 2015
$337.11M(+43.6%)
$100.06M(+18.2%)
Sep 2015
-
$84.65M(+3.7%)
Jun 2015
-
$81.63M(+15.4%)
Mar 2015
-
$70.76M(+1.5%)
Dec 2014
$234.78M
$69.73M(+24.1%)
Sep 2014
-
$56.17M(-0.0%)
Jun 2014
-
$56.19M(+6.7%)
DateAnnualQuarterly
Mar 2014
-
$52.68M(+30.3%)
Dec 2013
$140.11M(+7.5%)
$40.44M(-1.9%)
Sep 2013
-
$41.23M(+37.4%)
Jun 2013
-
$30.00M(+5.5%)
Mar 2013
-
$28.45M(-10.7%)
Dec 2012
$130.29M(-5.3%)
$31.85M(-8.8%)
Sep 2012
-
$34.91M(+5.9%)
Jun 2012
-
$32.95M(+7.7%)
Mar 2012
-
$30.59M(-10.1%)
Dec 2011
$137.57M(-4.3%)
$34.04M(+2.4%)
Sep 2011
-
$33.23M(-1.5%)
Jun 2011
-
$33.73M(-7.8%)
Mar 2011
-
$36.57M(+9.9%)
Dec 2010
$143.78M(-3.3%)
$33.27M(-8.6%)
Sep 2010
-
$36.40M(-4.8%)
Jun 2010
-
$38.24M(+6.6%)
Mar 2010
-
$35.87M(+3.4%)
Dec 2009
$148.64M(+19.9%)
$34.70M(+2.3%)
Sep 2009
-
$33.90M(-27.9%)
Jun 2009
-
$47.01M(+42.3%)
Mar 2009
-
$33.04M(+2.5%)
Dec 2008
$124.00M(-13.9%)
$32.22M(+11.2%)
Sep 2008
-
$28.97M(-21.0%)
Jun 2008
-
$36.66M(+40.2%)
Mar 2008
-
$26.15M(+23.8%)
Dec 2007
$144.07M(+116.9%)
$21.12M(-68.8%)
Sep 2007
-
$67.65M(+180.9%)
Jun 2007
-
$24.09M(-22.8%)
Mar 2007
-
$31.21M(+83.9%)
Dec 2006
$66.43M(+35.1%)
$16.97M(+0.9%)
Sep 2006
-
$16.82M(-1.8%)
Jun 2006
-
$17.13M(+10.4%)
Mar 2006
-
$15.51M(-5.8%)
Dec 2005
$49.19M(+34.6%)
$16.47M(+36.3%)
Sep 2005
-
$12.08M(-1.9%)
Jun 2005
-
$12.31M(+47.9%)
Mar 2005
-
$8.32M(+1.8%)
Dec 2004
$36.54M(+77.2%)
$8.18M(+4.9%)
Sep 2004
-
$7.79M(+9.7%)
Jun 2004
-
$7.11M(-47.2%)
Mar 2004
-
$13.47M(+654.8%)
Dec 2003
$20.62M(+388.5%)
-
Jun 2003
-
$1.78M(+40.9%)
Mar 2003
-
$1.27M
Dec 2002
$4.22M
-

FAQ

  • What is Alnylam Pharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual total expenses year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly total expenses year-on-year change?

What is Alnylam Pharmaceuticals annual total expenses?

The current annual total expenses of ALNY is $2.43B

What is the all time high annual total expenses for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual total expenses is $2.43B

What is Alnylam Pharmaceuticals annual total expenses year-on-year change?

Over the past year, ALNY annual total expenses has changed by +$314.66M (+14.91%)

What is Alnylam Pharmaceuticals quarterly total expenses?

The current quarterly total expenses of ALNY is $576.11M

What is the all time high quarterly total expenses for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly total expenses is $698.33M

What is Alnylam Pharmaceuticals quarterly total expenses year-on-year change?

Over the past year, ALNY quarterly total expenses has changed by +$38.34M (+7.13%)
On this page